Neogen Corp. (NEOG) financials: revenue, earnings and cash flow
Fiscal 2017–2026 + TTM · from SEC filings · data as of November 16, 2026
Summary
Neogen’s revenue went from $358M in fiscal 2017 to $870M in fiscal 2026, growth of about 10.4% a year.
Net income in fiscal 2026 was -$8M, a net margin of -0.9%; the best year in this period was 2018 with $63M.
Over the twelve months to August 31, 2026, revenue was $884M and net income -$56M.
Free cash flow was $32M in fiscal 2026 and positive in 7 of the 10 years shown.
The diluted share count rose 113% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $884M | $870M | $895M | $924M | $822M | $527M | $468M | $418M | $414M | $398M | $358M |
| Gross profit | $419M | $408M | $421M | $464M | $406M | $243M | $215M | $196M | $192M | $186M | $169M |
| Operating income | -$7M | -$22M | -$1.1B | $59M | $38M | $59M | $74M | $68M | $68M | $70M | $65M |
| Net income | -$56M | -$8M | -$1.1B | -$9M | -$23M | $48M | $61M | $59M | $60M | $63M | $44M |
| EPS (diluted) | $-0.26 | $-0.04 | $-5.03 | $-0.04 | $-0.12 | $0.45 | $0.57 | $0.56 | $0.57 | $0.60 | $0.43 |
| R&D | $20M | $18M | $21M | $22M | $26M | $17M | $16M | $15M | $13M | $11M | $10M |
| Revenue growth | — | −2.7% | −3.2% | +12.4% | +56.0% | +12.5% | +12.0% | +1.0% | +4.1% | +11.1% | +11.5% |
Cash flow
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $85M | $83M | $58M | $35M | $41M | $68M | $81M | $86M | $64M | $69M | $60M |
| Capital spending | -$36M | -$51M | -$105M | -$111M | -$66M | -$24M | -$27M | -$24M | -$15M | -$21M | -$15M |
| Free cash flow | $50M | $32M | -$46M | -$76M | -$25M | $44M | $54M | $62M | $49M | $48M | $46M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | — | — | — | — | — | — | — | — | $3M | — | — |
| Stock-based pay | $12M | $13M | $17M | $14M | $10M | $7M | $6M | $6M | $6M | $5M | $5M |
Balance sheet
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $186M | $129M | $171M | $246M | $381M | $381M | $344M | $268M | $211M | $144M |
| Debt | — | $819M | $921M | $918M | $1.8B | $3M | $2M | $2M | $2M | — | — |
| Equity | — | $2.1B | $2.1B | $3.1B | $3.1B | $887M | $840M | $725M | $638M | $560M | $472M |
| Total assets | — | $3.3B | $3.4B | $4.5B | $4.6B | $993M | $920M | $797M | $696M | $618M | $528M |
| Shares (diluted) | 218M | 218M | 217M | 216M | 189M | 108M | 107M | 106M | 105M | 104M | 102M |
Margins and returns
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 47.4% | 46.9% | 47.1% | 50.2% | 49.4% | 46.1% | 45.9% | 46.9% | 46.3% | 46.8% | 47.1% |
| Operating margin | -0.8% | -2.5% | -118.6% | 6.3% | 4.6% | 11.1% | 15.8% | 16.2% | 16.4% | 17.6% | 18.1% |
| Net margin | -6.3% | -0.9% | -122.0% | -1.0% | -2.8% | 9.2% | 13.0% | 14.2% | 14.5% | 15.9% | 12.2% |
| FCF margin | 5.6% | 3.7% | -5.2% | -8.2% | -3.0% | 8.3% | 11.6% | 14.8% | 11.9% | 12.1% | 12.8% |
| ROIC | — | -0.7% | -34.2% | 0.9% | 0.6% | 5.3% | 7.1% | 7.6% | 8.8% | 10.8% | 9.1% |
| ROE | — | -0.4% | -52.7% | -0.3% | -0.7% | 5.4% | 7.2% | 8.2% | 9.4% | 11.3% | 9.3% |
Frequently asked questions
What is Neogen’s annual revenue?
$870M in fiscal 2026 and $884M over the twelve months to August 31, 2026.
How much profit does Neogen make?
Net income was -$8M in fiscal 2026 (net margin -0.9%).
Is Neogen’s revenue growing?
No: revenue fell 2.7% in fiscal 2026 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.